235 related articles for article (PubMed ID: 26160442)
1. Blockade of KCa3.1 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction.
Ju CH; Wang XP; Gao CY; Zhang SX; Ma XH; Liu C
Cell Physiol Biochem; 2015; 36(4):1305-15. PubMed ID: 26160442
[TBL] [Abstract][Full Text] [Related]
2. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
[TBL] [Abstract][Full Text] [Related]
3. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
4. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
[TBL] [Abstract][Full Text] [Related]
5. Leonurine Attenuates Myocardial Fibrosis Through Upregulation of miR-29a-3p in Mice Post-myocardial Infarction.
Wang R; Peng L; Lv D; Shang F; Yan J; Li G; Li D; Ouyang J; Yang J
J Cardiovasc Pharmacol; 2021 Feb; 77(2):189-199. PubMed ID: 33235025
[TBL] [Abstract][Full Text] [Related]
6. K
She G; Ren YJ; Wang Y; Hou MC; Wang HF; Gou W; Lai BC; Lei T; Du XJ; Deng XL
J Am Heart Assoc; 2019 Jan; 8(1):e010418. PubMed ID: 30563389
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress promotes myocardial fibrosis by upregulating K
Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
Pflugers Arch; 2017 Sep; 469(9):1061-1071. PubMed ID: 28455747
[TBL] [Abstract][Full Text] [Related]
8. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.
Huang C; Shen S; Ma Q; Gill A; Pollock CA; Chen XM
Nephrol Dial Transplant; 2014 Feb; 29(2):313-24. PubMed ID: 24166472
[TBL] [Abstract][Full Text] [Related]
9. The role of KCa3.1 channels in cardiac fibrosis induced by pressure overload in rats.
Zhao LM; Wang LP; Wang HF; Ma XZ; Zhou DX; Deng XL
Pflugers Arch; 2015 Nov; 467(11):2275-85. PubMed ID: 25715999
[TBL] [Abstract][Full Text] [Related]
10. (Pro)renin Receptor Blockade Ameliorates Cardiac Injury and Remodeling and Improves Function After Myocardial Infarction.
Ellmers LJ; Rademaker MT; Charles CJ; Yandle TG; Richards AM
J Card Fail; 2016 Jan; 22(1):64-72. PubMed ID: 26362519
[TBL] [Abstract][Full Text] [Related]
11. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
12. Blockade of KCa3.1: A novel target to treat TGF-β1 induced conjunctival fibrosis.
Anumanthan G; Wilson PJ; Tripathi R; Hesemann NP; Mohan RR
Exp Eye Res; 2018 Feb; 167():140-144. PubMed ID: 29242028
[TBL] [Abstract][Full Text] [Related]
13. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
Chen CL; Liao JW; Hu OY; Pao LH
Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II upregulates K(Ca)3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts.
Wang LP; Wang Y; Zhao LM; Li GR; Deng XL
Biochem Pharmacol; 2013 May; 85(10):1486-94. PubMed ID: 23500546
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg2 attenuates myocardial fibrosis and improves cardiac function after myocardial infarction via AKT signaling pathway.
Li X; Xiang N; Wang Z
Biosci Biotechnol Biochem; 2020 Nov; 84(11):2199-2206. PubMed ID: 32706304
[TBL] [Abstract][Full Text] [Related]
17. Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrains.
Cardin S; Scott-Boyer MP; Praktiknjo S; Jeidane S; Picard S; Reudelhuber TL; Deschepper CF
Hypertension; 2014 Nov; 64(5):1040-6. PubMed ID: 25069667
[TBL] [Abstract][Full Text] [Related]
18. Absence of Myostatin Improves Cardiac Function Following Myocardial Infarction.
Lim S; McMahon CD; Matthews KG; Devlin GP; Elston MS; Conaglen JV
Heart Lung Circ; 2018 Jun; 27(6):693-701. PubMed ID: 28690022
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-132 attenuated cardiac fibrosis in myocardial infarction-induced heart failure rats.
Wang G; Wang R; Ruan Z; Liu L; Li Y; Zhu L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32885809
[TBL] [Abstract][Full Text] [Related]
20. Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPARγ.
Shen S; Jiang H; Bei Y; Zhang J; Zhang H; Zhu H; Zhang C; Yao W; Wei C; Shang H; Li X
Cell Physiol Biochem; 2017; 42(3):876-888. PubMed ID: 28647730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
